Related Experiment Video
Updated: Jun 28, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells
Shinichi Fukushige1, Emiko Kondo1, Akira Horii1
1Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
Abstract:
DNA methylation and histone modifications are both major features of the epigenetic silencing seen at tumor suppressor genes (TSGs) in cancer. DNA methylation inhibitors, but not, in general, histone deacetylase, can reactivate TSGs. However, DNA methylation inhibitors frequently upregulate genes whose promoters remain unmethylated. Herein we demonstrated that the methyl-CpG targeted transcriptional activation (MeTA), which allows re-expression of TSGs without DNA demethylation, is widely seen in human cancer. We further analyzed MeTA and found that transcriptional coactivators are recruited at hypermethylated promoter regions of TSGs using the methyl-CpG binding domain (MBD). Reactivation of MLH1 by MeTA accompanied acetylation of histone H3 lysine 9/14 at the promoter region. Furthermore, all ten genes analyzed in three cell lines were reactivated by the effect of MeTA. Our present results lead to an efficient way to search for transcriptionally silenced genes with highly methylated CpG islands, particularly TSGs in cancer and developmentally important genes in embryonic stem cells.
Insights
Methyl-CpG Targeted Transcriptional Activation (MeTA) reactivates tumor suppressor genes in cancer without DNA demethylation. This epigenetic mechanism recruits coactivators to methylated promoters, offering a new strategy for identifying silenced genes.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Biology
Background:
- Epigenetic silencing, involving DNA methylation and histone modifications, frequently inactivates tumor suppressor genes (TSGs) in cancer.
- Current DNA methylation inhibitors can reactivate TSGs but often affect unmethylated genes.
- Histone deacetylase inhibitors are generally less effective at reactivating TSGs.
Purpose of the Study:
- To demonstrate the prevalence of methyl-CpG targeted transcriptional activation (MeTA) in human cancer.
- To elucidate the mechanism by which MeTA reactivates TSGs without requiring DNA demethylation.
- To establish an efficient method for identifying transcriptionally silenced genes, particularly TSGs and developmentally important genes.
Main Methods:
- Analysis of MeTA in human cancer samples.
- Investigating the recruitment of transcriptional coactivators to hypermethylated promoter regions via methyl-CpG binding domains (MBDs).
- Assessing the reactivation of the MLH1 gene, including histone acetylation changes at its promoter.
Main Results:
- MeTA was found to be widely present in human cancer, enabling TSG re-expression without DNA demethylation.
- Transcriptional coactivators are recruited to hypermethylated TSG promoters through MBDs during MeTA.
- Reactivation of MLH1 by MeTA was associated with histone H3 lysine 9/14 acetylation at the promoter.
- All ten genes examined across three cell lines showed reactivation due to MeTA.
Conclusions:
- MeTA provides an efficient mechanism for reactivating epigenetically silenced tumor suppressor genes in cancer.
- The findings facilitate the identification of transcriptionally silenced genes with methylated CpG islands, including TSGs and crucial developmental genes.
- MeTA represents a novel epigenetic regulatory pathway with significant implications for cancer therapy and developmental biology research.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic cells are...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

